This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 120/14/1345    most recent CIRCULATIONAHA.108.846402v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Burger, D. E. Articles by Feng, Q. PubMed PubMed Citation Articles by Burger, D. E. Articles by Feng, Q. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Arrhythmia Heart Attack Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL Related Collections Animal models of human disease Arrythmias-basic studies Acute myocardial infarction Endothelium/vascular type/nitric oxide Related Article

(Circulation. 2009;120:1345-1354.)
© 2009 American Heart Association, Inc.

Arrhythmia/Electrophysiology

Neuronal Nitric Oxide Synthase Protects Against Myocardial Infarction-Induced Ventricular Arrhythmia and Mortality in Mice

Dylan E. Burger, PhD^*; Xiangru Lu, MD^*; Ming Lei, MD; Fu-Li Xiang, MD; Lamis Hammoud, PhD; Mao Jiang, PhD; Hao Wang, MD, PhD; Douglas L. Jones, PhD; Stephen M. Sims, PhD; Qingping Feng, MD, PhD

From the Departments of Physiology and Pharmacology (D.E.B., F.-L.X., L.H., M.J., D.L.J., S.M.S, Q.F.), Medicine (M.L., D.L.J., Q.F.), and Surgery (H.W.), University of Western Ontario, and Lawson Health Research Institute (X.L., H.W., D.L.J., Q.F.), London, Ontario, Canada.

Correspondence to Dr Qingping Feng, Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada N6A 5C1. E-mail qfeng{at}uwo.ca

Received July 3, 2008; accepted July 2, 2009.

Background— Neuronal nitric oxide synthase (nNOS) is expressed in cardiomyocytes and plays a role in regulating cardiac function and Ca²⁺ homeostasis. However, the role of nNOS in cardiac electrophysiology after myocardial infarction (MI) is unclear. We hypothesized that nNOS deficiency increases ventricular arrhythmia and mortality after MI.

Methods and Results— MI was induced in wild-type (WT) or nNOS^–/– mice by ligation of the left coronary artery. Thirty-day mortality was significantly higher in nNOS^–/– compared with WT mice. Additionally, nNOS^–/– mice had impaired cardiac function 2 days after MI. Telemetric ECG monitoring showed that compared with WT, nNOS^–/– mice had significantly more ventricular arrhythmias and were more likely to develop ventricular fibrillation after MI. Treatment with the L-type Ca²⁺ channel blocker verapamil reduced the incidence of arrhythmia and ventricular fibrillation in nNOS^–/– mice after MI. To assess the role of nNOS in Ca²⁺ handling, patch-clamp and Ca²⁺ fluorescence techniques were used. Ca²⁺ transients and L-type Ca²⁺ currents were higher in nNOS^–/– compared with WT cardiomyocytes. Additionally, nNOS^–/– cardiomyocytes exhibited significantly higher systolic and diastolic Ca²⁺ over a range of pacing frequencies. Treatment with the NO donor S-nitroso N-acetyl-penicillamine decreased Ca²⁺ transients and L-type Ca²⁺ current in both nNOS^–/– and WT cardiomyocytes. Furthermore, S-nitrosylation of Ca²⁺ handling proteins was significantly decreased in nNOS^–/– myocardium after MI.

Conclusions— Deficiency in nNOS increases ventricular arrhythmia and mortality after MI in mice. The antiarrhythmic effect of nNOS involves inhibition of L-type Ca²⁺ channel activity and regulation of Ca²⁺ handling proteins via S-nitrosylation.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2009 120: 1337-1338. [Extract] [Full Text]